The Biomarker: Melanoma

Sanjiv S. Agarwala, MD
Video Categories: The Biomarker

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
December 12, 2016

Patient Preferences

Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.

September 20, 2013

Personalized Medicine and the Affordable Care Act

Grant Lawless discusses the long term goal of personalized medicine as it relates to the Affordable Care Act